CA2495563A1 - Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation - Google Patents
Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation Download PDFInfo
- Publication number
- CA2495563A1 CA2495563A1 CA002495563A CA2495563A CA2495563A1 CA 2495563 A1 CA2495563 A1 CA 2495563A1 CA 002495563 A CA002495563 A CA 002495563A CA 2495563 A CA2495563 A CA 2495563A CA 2495563 A1 CA2495563 A1 CA 2495563A1
- Authority
- CA
- Canada
- Prior art keywords
- novx
- polypeptide
- protein
- nucleic acid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne des séquences d'acides nucléiques codant pour de nouveaux polypeptides. L'invention concerne également des polypeptides codés par lesdites séquences d'acides nucléiques, et des anticorps qui se lient de manière immunospécifique au polypeptide ainsi que des dérivés, des variantes, des mutants, ou des fragments du nouveau polypeptide, polynucléotide ou anticorps spécifiques dudit polypeptide. L'invention concerne, en outre, des vecteurs, des cellules hôtes, des anticorps et des méthodes de recombinaison permettant de produire lesdits polypeptides et polynucléotides ainsi que des méthodes permettant de les utiliser. L'invention concerne enfin des méthodes thérapeutiques, diagnostiques et de recherche à des fins de diagnostic, de traitement et de prévention de troubles impliquant l'un quelconque de ces nouveaux acides nucléiques et protéines humains.
Applications Claiming Priority (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40159702P | 2002-08-07 | 2002-08-07 | |
US60/401,597 | 2002-08-07 | ||
US40220502P | 2002-08-09 | 2002-08-09 | |
US40220902P | 2002-08-09 | 2002-08-09 | |
US60/402,205 | 2002-08-09 | ||
US60/402,209 | 2002-08-09 | ||
US40354802P | 2002-08-13 | 2002-08-13 | |
US40351702P | 2002-08-13 | 2002-08-13 | |
US60/403,548 | 2002-08-13 | ||
US60/403,517 | 2002-08-13 | ||
US40369602P | 2002-08-15 | 2002-08-15 | |
US60/403,696 | 2002-08-15 | ||
US40631802P | 2002-08-26 | 2002-08-26 | |
US60/406,318 | 2002-08-26 | ||
US40620202P | 2002-08-27 | 2002-08-27 | |
US60/406,202 | 2002-08-27 | ||
US10/236,392 US20040067490A1 (en) | 2001-09-07 | 2002-09-06 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
US10/236,392 | 2002-09-06 | ||
US10/242,943 | 2002-09-13 | ||
US10/242,943 US20030087412A1 (en) | 1998-10-06 | 2002-09-13 | Nlk1 protein and Nlk1 protein complexes |
US42313802P | 2002-11-01 | 2002-11-01 | |
US60/423,138 | 2002-11-01 | ||
US10/635,149 | 2003-08-06 | ||
US10/635,149 US20050049192A1 (en) | 1999-06-03 | 2003-08-06 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
PCT/US2003/024931 WO2004015079A2 (fr) | 2002-08-07 | 2003-08-07 | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2495563A1 true CA2495563A1 (fr) | 2004-02-19 |
Family
ID=31722010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002495563A Abandoned CA2495563A1 (fr) | 2002-08-07 | 2003-08-07 | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1539807A4 (fr) |
JP (1) | JP2006515753A (fr) |
AU (1) | AU2003259704A1 (fr) |
CA (1) | CA2495563A1 (fr) |
WO (1) | WO2004015079A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4863452B2 (ja) * | 2006-03-30 | 2012-01-25 | 国立大学法人 千葉大学 | ヒトTh1/Th2分化誘導系及びその用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846770A (en) * | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
PT1632499E (pt) * | 1999-03-08 | 2007-09-11 | Genentech Inc | Dispositivo de detecção de impacto para automóveis. |
AU4196801A (en) * | 2000-03-02 | 2001-09-12 | Amgen Inc | Chordin-like-2 molecules and uses thereof |
AU2002243495A1 (en) * | 2001-01-12 | 2002-07-24 | University Of Medicine And Dentistry Of New Jersey | Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
US20030134790A1 (en) * | 2002-01-11 | 2003-07-17 | University Of Medicine And Dentistry Of New Jersey | Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer |
-
2003
- 2003-08-07 JP JP2005506604A patent/JP2006515753A/ja active Pending
- 2003-08-07 CA CA002495563A patent/CA2495563A1/fr not_active Abandoned
- 2003-08-07 AU AU2003259704A patent/AU2003259704A1/en not_active Abandoned
- 2003-08-07 EP EP03785086A patent/EP1539807A4/fr not_active Withdrawn
- 2003-08-07 WO PCT/US2003/024931 patent/WO2004015079A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004015079A2 (fr) | 2004-02-19 |
AU2003259704A1 (en) | 2004-02-25 |
JP2006515753A (ja) | 2006-06-08 |
WO2004015079A3 (fr) | 2004-09-02 |
EP1539807A4 (fr) | 2006-09-06 |
EP1539807A2 (fr) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2486490A1 (fr) | Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation | |
US20030199442A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
US20030219823A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003078572A2 (fr) | Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et procedes d'utilisation | |
EP1572922A2 (fr) | Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation | |
WO2003085124A2 (fr) | Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees | |
US20060234255A1 (en) | Novel proteins and nucleic acids encoding same | |
US20030229016A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
US20040067505A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2004089282A2 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides, et procedes d'utilisation correspondants | |
CA2471480A1 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
US20040229779A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
CA2481039A1 (fr) | Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation | |
CA2495563A1 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation | |
US20050037957A1 (en) | Novel proteins and nucleic acids encoding same | |
US20040002453A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
CA2485089A1 (fr) | Polypeptides therapeutiques, acides nucleiques codant pour lesdits polypeptides et methodes d'utilisation | |
US20060234257A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
CA2467721A1 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation | |
US20040259774A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
US20050049192A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
US20040058347A1 (en) | Novel proteins and nucleic acids encoding same | |
EP1565199A2 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation | |
AU2003210852A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2004015076A2 (fr) | Nouvelles proteines et acides nucleiques les codant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |